• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Anti-RUC suit challenges process for setting doc pay scales

Anti-RUC suit challenges process for setting doc pay scales

December 1, 2011 By MassDevice Contributors Network

By Merrill Goozner

Merrill Goozner

Whither CMS? That’s the issue raised by Brian Klepper and David Kibbe in their post on the Health Affairs website this morning.

The Center for Medicare and Medicaid Services faces a November deadline for answering a complaint by six Georgia physicians that claims the American Medical Association’s Relative Value Scale Update Committee (RUC) violates the Federal Advisory Committee Act.

The RUC periodically sends recommendations to CMS on how it should reimburse different physician services. As Klepper and Kibbe point out, this specialist-dominated committee, after what are the medical equivalent the early 20th century factory efficiency studies conducted by Frederick Winslow Taylor, decides that the value of cataract surgery, for instance, is 12.5 times the value of a primary care office visit.

Sign up to get our free newsletters delivered straight to your inbox

CMS invariably follows the RUC’s recommendations, making it for all intents and purposes, a quasi-official federal advisory committee.

I know a bit about FACA, since I spent five years of my life trying to get federal agencies to follow the requirements of that 1972 statute.

Once dubbed the fifth branch of government, there are now nearly 1,000 federal advisory committees, most of them comprised of outside scientists and experts offering advice to regulatory agencies ranging from CMS and the FDA (I’ve sat on several of theirs as a consumer representative) to the Defense and Energy Departments.

They are required to have an open process in selecting members. The roster of experts must be adequately balanced to reflect a range of views on the issues before the committee. They also must not have conflicts of interest, although that requirement can be waived when a person’s expertise is deemed unique and vital to the performance of the committee’s tasks.

Meetings must be open, and allow public engagement.

Without having investigated the matter, I think I can assert with some certainty that the AMA’s RUC does not meet all of those standards. Heck, it might not meet any of them. CMS should intervene in this suit . . . on the side of the plaintiffs.

There’s no reason for a federal agency to continue using the recommendations of an advisory committee that doesn’t meet the legal standard that is used by every other federal agency and the National Academies (including the Institute of Medicine).

Last week, I stopped by a Health Affairs briefing and asked CMS administrator Donald Berwick if he was going to follow the RUC’s latest recommendation, which is intended to boost the “relative value” of primary care. He said he would take it under careful consideration. He even shook my hand afterwards, which I took as a “thank you” for asking the question. None of the trade press that routinely follows Berwick around to his public appearances seemed to be aware that the issue was even under discussion.

Successful medicine in the 21st century will be delivered by multidisciplinary teams. Just as Taylorism in manufacturing was vanquished by the Toyota way, the specialist-driven model of health care delivery that dominated the late 20th century needs to be replaced by a more efficient system of salaried physicians working in teams delivering higher quality care. The RUC has no place in such a system.

Opening the RUC up to a democratic process that engages all the stakeholders in health care is the first step toward making that obvious.

Merrill Goozner is an award-winning journalist and author of “The $800 Million Pill: The Truth Behind the Cost of New Drugs” who writes regularly at Gooznews.com.

Filed Under: Blog, News Well Tagged With: American Medical Assn., Centers for Medicare and Medicaid Services (CMS), Gooz News

More recent news

  • Medtronic partners with IRCAD on Hugo, Affera surgical training
  • 23andMe co-founder wins bid to take back control of company
  • Neurent Medical opens new manufacturing facility in Ireland
  • Brain Navi wins FDA nod for neurosurgical robot
  • Adona Medical completes enrollment in first-in-human interatrial shunt trial

Private: Anti-RUC Suit Challenges Process for Setting Doc Pay Scales

October 25, 2011 By MassDevice Leave a Comment

Whither CMS? That’s the issue raised by Brian Klepper and David Kibbe in their post on the Health Affairs website this morning. The Center for Medicare and Medicaid Services faces a November deadline for answering a complaint by six Georgia physicians that claims the American Medical Association’s Relative Value Scale Update Committee (RUC) violates the Federal Advisory Committee Act. The RUC periodically sends recommendations to CMS on how it should reimburse different physician services. As Klepper and Kibbe point out, this specialist-dominated committee, after what are the medical equivalent the early 20th century factory efficiency studies conducted by Frederick Winslow Taylor, decides that the value of cataract surgery, for instance, is 12.5 times the value of a primary care office visit.

CMS invariably follows the RUC’s recommendations, making it for all intents and purposes, a quasi-official federal advisory committee. I know a bit about FACA, since I spent five years of my life trying to get federal agencies to follow the requirements of that 1972 statute. Once dubbed the fifth branch of government, there are now nearly 1,000 federal advisory committees, most of them comprised of outside scientists and experts offering advice to regulatory agencies ranging from CMS and the FDA (I’ve sat on several of theirs as a consumer representative) to the Defense and Energy Departments. They are required to have an open process in selecting members. The roster of experts must be adequately balanced to reflect a range of views on the issues before the committee. They also must not have conflicts of interest, although that requirement can be waived when a person’s expertise is deemed unique and vital to the performance of the committee’s tasks. Meetings must be open, and allow public engagement.

Without having investigated the matter, I think I can assert with some certainty that the AMA’s RUC does not meet all of those standards. Heck, it might not meet any of them. CMS should intervene in this suit . . . on the side of the plaintiffs. There’s no reason for a federal agency to continue using the recommendations of an advisory committee that doesn’t meet the legal standard that is used by every other federal agency and the National Academies (including the Institute of Medicine).

Last week, I stopped by a Health Affairs briefing and asked CMS administrator Donald Berwick if he was going to follow the RUC’s latest recommendation, which is intended to boost the “relative value” of primary care. He said he would take it under careful consideration. He even shook my hand afterwards, which I took as a “thank you” for asking the question. None of the trade press that routinely follows Berwick around to his public appearances seemed to be aware that the issue was even under discussion.

Successful medicine in the 21st century will be delivered by multidisciplinary teams. Just as Taylorism in manufacturing was vanquished by the Toyota way, the specialist-driven model of health care delivery that dominated the late 20th century needs to be replaced by a more efficient system of salaried physicians working in teams delivering higher quality care. The RUC has no place in such a system. Opening the RUC up to a democratic process that engages all the stakeholders in health care is the first step toward making that obvious.

Filed Under: Uncategorized

More recent news

  • Medtronic partners with IRCAD on Hugo, Affera surgical training
  • 23andMe co-founder wins bid to take back control of company
  • Neurent Medical opens new manufacturing facility in Ireland
  • Brain Navi wins FDA nod for neurosurgical robot
  • Adona Medical completes enrollment in first-in-human interatrial shunt trial

Reader Interactions

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy